LivaNova LIVN
NASDAQ LIVN
$78.02 -2.82 (-3.49%)
At close: Aug 20, 2026 · 1:39 PM UTC

LivaNova (LIVN) Cash & Current Investments (2014 - 2026)

LivaNova (LIVN) posted Cash & Current Investments of $539.7 million for Q1 2026, down 15.08% sequentially from $635.6 million in Q4 2025, and down 26.91% YoY from $738.4 million in Q1 2025.

LivaNova (LIVN) Cash & Current Investments (2014 - 2026) Analysis & Trends

LivaNova has reported Cash & Current Investments for 13 years, with the latest figure at $539.7 million in Q1 2026.

  • Quarterly Cash & Current Investments fell 26.91% year-over-year to $539.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $539.7 million (down 26.91% YoY) and the FY2025 annual result came in at $635.6 million, up 48.2% from the prior year.
  • Cash & Current Investments declined to $539.7 million in Q1 2026 per LIVN's latest filing, from $635.6 million in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $738.4 million in Q1 2025 and troughed at $276.0 million in Q3 2022.
  • A 5-year average of $381.5 million and a median of $311.4 million in 2023 frame the typical range for Cash & Current Investments.
  • The widest YoY moves for Cash & Current Investments: up 183.96% in 2022, down 30.93% in 2022.
  • Over 5 years, Cash & Current Investments stood at $302.8 million in 2022, then advanced by 2.84% to $311.4 million in 2023, then jumped by 37.73% to $428.9 million in 2024, then surged by 48.2% to $635.6 million in 2025, then retreated by 15.08% to $539.7 million in 2026.
  • According to Business Quant data, Cash & Current Investments over the past three periods registered $539.7 million, $635.6 million, and $738.4 million for Q1 2026, Q4 2025, and Q1 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Abbott Laboratories 198.91 Bn 193.31 Bn 7.27 Bn 5.60 Bn
2 Stryker 127.59 Bn 124.11 Bn 4.50 Bn 3.48 Bn
3 Medtronic 118.77 Bn 109.55 Bn 6.41 Bn 9.22 Bn
4 Boston Scientific 73.24 Bn 72.70 Bn 3.85 Bn 539.00 Mn
5 Edwards Lifesciences 51.91 Bn 47.66 Bn 1.35 Bn 4.25 Bn
6 Dexcom 34.38 Bn 32.44 Bn 830.00 Mn 1.95 Bn
7 GE HealthCare Technologies 33.96 Bn 31.85 Bn 2.18 Bn 2.11 Bn
8 Koninklijke Philips 26.36 Bn 23.04 Bn 4.55 Bn 3.32 Bn
9 Steris 23.08 Bn 22.60 Bn 684.20 Mn 482.30 Mn
10 LivaNova 4.29 Bn 3.77 Bn 273.67 Mn 516.62 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 516.62 Mn
Mar 31, 2026 539.71 Mn
Dec 31, 2025 635.55 Mn
Mar 31, 2025 738.44 Mn
Dec 31, 2024 428.86 Mn
Sep 30, 2024 346.37 Mn
Jun 30, 2024 303.88 Mn
Mar 31, 2024 306.50 Mn
Dec 31, 2023 311.37 Mn
Sep 30, 2023 298.80 Mn
Jun 30, 2023 311.43 Mn
Mar 31, 2023 308.60 Mn
Dec 31, 2022 302.78 Mn
Sep 30, 2022 275.96 Mn
Jun 30, 2022 300.27 Mn
Mar 31, 2022 313.68 Mn
Dec 31, 2021 106.63 Mn
Sep 30, 2021 277.77 Mn
Jun 30, 2021 434.76 Mn
Mar 31, 2021 252.54 Mn